Financials

People

Activity

Triventures

Company

Investment-firm

Financing round

General

About Company
Triventures is a venture capital fund that invests in data-driven healthcare solutions and disruptive medical devices.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2008

Number of employees

IPO status

Private

Description

The global venture capital firm, founded in 2008 and headquartered in Herzliya, Tel Aviv, identifies cross-industry breakthroughs that converge health and non-health technologies such as insurtech, fintech, e-commerce, and cyber for healthcare, community-driven genomics, and health data marketplaces. Its team of key opinion leaders in healthcare, entrepreneurship, venturing, and corporate business development has decades of accumulated industry experience and relationships. Triventures has strong partnerships with healthech companies, healthcare providers, and consumer electronics companies, enabling it to contribute significant value to its portfolio companies when commercially integrating into markets.
Contacts

Contact Email

Social url

Similar Companies
491
NextGen Ventures

NextGen Ventures

NextGen Ventures invests in digital health and medtech startups to improve healthcare.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

6741 Lunteren, Netherlands

count Of Investments

14
HealthX Ventures

HealthX Ventures

HealthX Ventures is a digital healthcare-focused seed fund.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Madison, WI, USA

count Of Investments

33

count Of Exists

2
HealthXCapital

HealthXCapital

HealthXCapital is Asia's first healthtech venture capital fund, investing in innovative health tech solutions for South and Southeast Asia.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital, Financial Services

Location

Singapore

count Of Investments

8
New Leaf Venture Partners

New Leaf Venture Partners

New Leaf Venture Partners is a venture capital firm that invests in healthcare technology companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

New York, NY, USA

count Of Investments

138

count Of Exists

33

Financials

Investments
34
Date 
name 
Lead 
type 
Raised 
19.10.2022
Yes
$9M
04.04.2022
No
$25M
01.04.2022
Yes
$3.51M
FEMSelect

FEMSelect

FEMSelect is a medical device company that offers an innovative technology platform for women's health.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Women, Medical Device

Location

Modi'in-Maccabim-Re'ut, Israel

total rounds

6

total raised

$13.34M
Future Family

Future Family

Future Family is a subscription fertility company that offers easy plans for IVF and egg freezing with on-demand medical support.

Sector

Health Care Providers

Subsector

Health Care Facilities

Location

San Francisco, CA, USA

total rounds

9

total raised

$148.2M

count Of Investments

1
PayGround

PayGround

PayGround simplifies healthcare bill-pay by unifying providers and patients on a single payment platform.

Sector

Industrial Support Services

Subsector

Transaction Processing Services

Keywords

Health Care, Billing, Payments

Location

Phoenix, AZ, USA

total rounds

5

total raised

$27.21M
Co-Investors
Exits
6
Cardiva Medical

Cardiva Medical

Cardiva Medical is a medical device company developing and commercializing innovative vascular closure technology.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Sunnyvale, CA, USA

total rounds

13

total raised

$181.24M
Apica Cardiovascular

Apica Cardiovascular

Apica Cardiovascular is a developer of cardiovascular devices.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Galway, Ireland

total rounds

2

total raised

$6.64M
OrthoSpace

OrthoSpace

OrthoSpace develops biodegradable balloon systems for the orthopaedic market.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Biotechnology

Location

Caesarea, Israel

total rounds

4

total raised

$15M

People

Founders
3
Martin Leon
Martin Leon

Martin Leon

Martin Leon is Professor of Medicine at Columbia University Medical Center (CUMC). Martin Leon is also Director of the Center for Interventional Vascular Therapy (CIVT), Director of the Cardiac Catheterization Laboratories, and on the Executive Board of the Columbia New York Presbyterian Heart Valve Center. He continues as a practicing Interventional cardiologist at New York-Presbyterian Hospital in New York City. Martin Leon is the Founder and Chairman Emeritus of the Cardiovascular Research Foundation. Martin Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Martin Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 26th anniversary. Martin Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Martin Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens. Martin Leon was previously the Director of Cardiovascular Research and Education at the Lenox Hill Heart and Vascular Institute in New York. Prior to that, he was Director of Clinical Research at the Washington Cardiology Center at the Washington Hospital Center and Clinical Professor of Medicine at Georgetown University Medical Center in Washington, DC. Earlier in his career, he served as a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD. He was a founder of the Washington Cardiology Center and the Cardiology Research Foundation in Washington, DC.

current job

Triventures
Triventures

Martin Leon

Peter Fitzgerald
Peter Fitzgerald

Peter Fitzgerald

Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering at Stanford. Presently, Peter Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program Peter has been principle/founder of eighteen medical device companies in the San Francisco Bay Area. He has transitioned twelve of these start-ups to large medical device companies.

current job

Triventures
Triventures

Peter Fitzgerald

Michal Geva
Michal Geva

Michal Geva

Michal Geva has over 15 years of extensive hands-on experience in Israeli and American medical device companies. She has held executive roles in regulatory & clinical affairs, and/or quality assurance and marketing at ByPass, a developer of a cardiovascular anastomotic device (collaborated with J&J), AST, a developer of a stent and stent delivery system (acquired by Boston Scientific for $120 million), and GI View, a developer of advanced endoscope technologies for the GI tract, among others. Michal has been an advisor to several American companies and funds with activities in Israel. Michal is a Co-Founder and a Managing Partner of TriVentures.

current job

Triventures
Triventures

Michal Geva

Employee Profiles
12
Netalie Nadivi

Netalie Nadivi

General Partner

Dani Goldsher

Dani Goldsher

CFO

Michal Geva

Michal Geva

Co-Founder and Managing Partner

Eva Hubsman

Eva Hubsman

CFO

Martin Leon

Martin Leon

Co-Founder and Venture Partner

Yodfat Harel Buchris

Yodfat Harel Buchris

Venture Partner

Lidia Verra

Lidia Verra

Controller

Ari Fried

Ari Fried

Principal

Activity

Recent News
0